International Clinical Trial: A Real-World Study of SGLT2 Inhibitors in Very Elderly Patients with Multiple Comorbidities

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119830) titled 'A Real-World Study of SGLT2 Inhibitors in Very Elderly Patients with Multiple Comorbidities' on March 4.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital

Condition: Chronic heart failure, chronic kidney disease (stages 3-4), type 2 diabetes, atherosclerotic cardiovascular disease (coronary heart disease, ischemic stroke, peripheral artery disease)

Intervention: Non-SGLT2i Control Group:NA

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-04

Target Sample Size: Non-SGLT2i Control Group:1500;...